This study investigates the use of digital and standardized documentation by patients of frequently occurring adverse events in oncological therapies.
This research study is structured as a Phase I and II clinical trial. In phase I, the feasibility of using a smartphone application to document adverse events that have occurred during oncological therapies by the patient will be investigated. In phase II we will investigate whether the use of the smartphone app allows an improvement of patient care by reducing occurred adverse events.
Study Type
OBSERVATIONAL
Enrollment
66
Standardized documentation of occurred side effects
Universitätsklinikum Ulm
Ulm, Germany
Phase I: Patient acceptance of a new medium of communication
Acceptance of documentation of occurring side effects of oncological therapies with new communication media
Time frame: 6 months
Phase II: Change of occurred adverse events
Changes of side effects by at least 1 degree according to CTCAE scoring in comparison to the study start
Time frame: 6 months
Phase II: Doses of chemotherapy
Maintenance of chemotherapy doses through better adverse event management
Time frame: 6 months
Phase II: Incidence of adverse events
Incidence of treatment-emergent adverse events as assessed by the CTCAE scale
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.